Skip to main content
. 2023 Dec 6;18:381. doi: 10.1186/s13023-023-02981-2

Table 2.

Crude incidence rates of death or invasive ventilation by current and average relative dose categories

Deaths Composite outcome: invasive ventilation or death
N (%) events Total PY, N (%) Crude incidence rate/100 PY N (%) events Total PY, N (%) Crude incidence rate/100 PY
Total events/person-time 88 (of 332 patients) 1609.4 5.47 97 (of 270 patients) 1236.8 7.84
Current dose category at the time of eventa
 None (not currently treated) 7 (8.0) 5.7 (0.4) 121.87 4 (4.1) 4.4 (0.4) 91.71
 Very low dose 0 7.9 (0.5) 0.00 1 (1.0) 7.5 (0.6) 13.30
 Label dose 65 (73.9) 948.6 (58.9) 6.85 71 (73.2) 707.5 (57.2) 10.03
 40 mg/kg EOW 3 (3.4) 224.6 (14.0) 1.34 7 (7.2) 184.0 (14.9) 3.80
 20 mg/kg/week 13 (14.8) 262.6 (16.3) 4.95 13 (13.4) 198.7 (16.1) 6.54
 40 mg/kg/week 0 160.1 (9.9) 0.00 1 (1.0) 134.7 (10.9) 0.74
Category of average relative dose over time at the time of eventb
 Below label dose 8 (9.1) 22.8 (1.4) 35.07 5 (5.2) 21.1 (1.7) 23.71
 Label dose 52 (59.1) 854.0 (53.1) 6.09 60 (61.9) 633.1 (51.2) 9.48
 Between label and double dose 14 (15.9) 339.2 (21.1) 4.13 16 (16.5) 283.9 (23.0) 5.63
Double dose 12 (13.6) 249.3 (15.5) 4.81 16 (16.5) 189.1 (15.3) 8.46
 Above double to quadruple dose 2 (2.3) 144.1 (9.0) 1.39 0 109.6 (8.9) 0.00

EOW, every other week; PY, person-years

aDose categories: 'Very low dose': > 0 to < 14 mg/kg EOW or weekly, 'Label dose': About the label dose of 20 mg/kg EOW, range of 14 to 27 mg/kg EOW, '40 mg/kg EOW': > 27 to 52 mg/kg EOW,' 20 mg/kg/week': 14 to 27 mg/kg/week, '40 mg/kg weekly': > 27 to 52 mg/kg/week. Patients receiving > 52 mg/kg EOW or weekly are censored at the date of their first such dose report

bAverage dose received from first treatment to the end of follow-up, in multiples of the label dose, ranging from > 0 to 4 times label dose. Average dose categories: 'Below label dose' is average dose < 0.95;'Label dose' is from 0.95 to < 1.05; 'Between label and double dose' is from 1.05 to < 1.75; 'Double dose' is 1.75 to < 2.25; 'Above double to quadruple dose' is 2.25 to 4.0